检索

Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus

Bagriy A., Shchukina E., Efremenko V., Mikhailichenko E., Suprun E.

(Rus)

卷 30, 编号 3 (2023)

Combination therapy for type 2 diabetes maintains its position. Clinical case

Podachina S., Biryukova E., Solovievа I.

(Rus)

编号 3 (2012)

SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS

Druk I., Nechaeva G., Korennova O., Druk I., Nechayeva G., Korennova O.

Tactics of hypoglycemic treatment in patients with pancreatogenic diabetes: a prospective study

Nikulin I., Bagriy A., Mikhailichenko E., Kutya A., Sovpel Y.

(Rus)

卷 29, 编号 4 (2022)

Type 3 diabetes mellitus: is there a chance to become famous?

Morgunov L.

(Rus)

卷 32, 编号 2 (2025)

Latent autoimmune diabetes in adults: current concepts of risk factors, diagnosis, and therapy

Druk I., Safronova S., Kulebakina K.

(Rus)

Possibilities of using insulin degludec in the treatment of diabetes mellitus in patients with previous ineffective insulin therapy: analysis of clinical cases

Elsukova O.

(Rus)

Vaccination against pneumococcal infection in patients with diabetes mellitus

Tarasova A., Kostinov M., Novopoltseva E.

(Rus)

卷 32, 编号 2 (2025)

Efficiency of a fixed combination of insulin glargine and lixisenatide in everyday clinical practice

Elsukova O., Nikitina E.

(Rus)

Clinical case of achieving compensation for type 2 diabetes mellitus in preparation for pregnancy in a woman of reproductive age

Markina J.

(Rus)

Vildagliptin – 15 years in active service with diabetologists

Pavlova M.

(Rus)

Theory and practice of use of dipeptidyl peptidase-4 inhibitors: focus on evogliptin

Biryukova E.

(Rus)

Diabetes mellitus and new coronavirus infection: a look into the past; conclusions on prevention and treatment tactics for the future

Aramisova L., Zhurtova I., Gubachikova A.

(Rus)

卷 30, 编号 3 (2023)

Metabolic comorbidity of endometritis after caesarean section

Korobkov N., Bakulina N., Borovik N.

(Rus)

卷 29, 编号 11/12 (2022)

Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review

Petunina N., Martirosyan N., Valeeva F.

(Rus)

卷 29, 编号 4 (2022)

Application of the diabetes screening questionnaire in patients with psoriasis

Morzhanaeva M., Svechnikova E., Shchepkina E., Kuznetsov A.

(Rus)

卷 28, 编号 12 (2021)

Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics

Shorokhova P., Baranov V.

(Rus)

Experience of insulin degludec treatment using constant glucose monitoring system (CGMS)

Smirnova E.

(Rus)

Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice

Antsiferov M., Zilov A., Koteshkova O., Demidov N.

(Rus)

卷 27, 编号 12 (2020)

Improvement of the efficacy of conservative treatment of rhinosinusitis and otitis media in patients with type 2 diabetes mellitus: an open-label prospective randomized clinical trial

Shkurova N., Baranova N., Fedin A.

(Rus)

卷 27, 编号 4 (2020)

Cranial neuropathy as a complication of diabetes mellitus

Maksimova M., Stepanchenko O.

(Rus)

卷 26, 编号 14 (2019)

Experience in the integrated use of organizational approaches and clinical tools to achieve glycemic control goals

Antsiferov M., Demidov N.

(Rus)

卷 26, 编号 4 (2019)

Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia

Pereverzev A., Ostroumova O., Tkacheva O.

(Rus)

卷 26, 编号 4 (2019)

Genetic predictors of the pharmacological effects of dipeptidyl peptidase-4 inhibitors and sulfonylureas in patients with type 2 diabetes mellitus

Shorokhova P., Baranov V., Vorokhobina N., Shpilevaya O.

(Rus)

编号 11 (2018)

Apelin: biological and pathophysiological effects

Dolgikh Y., Verbovoy A.

(Rus)

编号 16 (2017)

Opportunities for prevention of changes in skin and oral mucosa in diabetes mellitus at the present stage

Verbovoy A., Sharonova L., Burakshayev S., Kotelnikova E., Smirnova T.

(Rus)

编号 15 (2017)

Energy metabolism corrector Mildronate®: interrelation of mechanisms of action and therapeutic effects

Dzerve V.

(Rus)

编号 5 (2017)

PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS

Ametov A.

(Rus)

编号 16 (2016)

Clinical characteristics and practical aspects of the use of new basal insulin glargine 300 U/ml Toujeo SoloStar®

Antsiferov M.

(Rus)

编号 5 (2016)

EMPAGLIFLOZIN: ENHANCEMENT OF POTENTIALS OF THE TREATMENT OF TYPE 2 DIABETES MELLITUS

Biryukova E.

(Rus)

编号 17 (2015)

Rezul'taty monitoringa effektivnosti i bezopasnosti primeneniya preparatov rekombinantnogo insulina cheloveka Biosulin R i Biosulin N u bol'nykh sakharnym diabetom 2 tipa v real'noy klinicheskoy praktike

Demidov N., Zakharova S., Zav'yalov A.

(Rus)

编号 10 (2015)

Ingibitory dipeptidilpeptidazy-4: novye vozmozhnosti effektivnogo glikemicheskogo kontrolya putem korrektsii narusheniy zhirovogo obmena u patsientov s sakharnym diabetom 2 tipa

Gusenbekova D., Ametov A., Butaeva S.

(Rus)

编号 5 (2015)

Klinicheskaya inertsiya v terapii sakharnogo diabeta 2 tipa

Antsiferov M.

(Rus)

编号 16 (2014)

Kombinirovannaya terapiya bolevoy diabeticheskoy polineyropatii: rezul'taty pilotnogo issledovaniya

Khramilin V., Andreeva V., Demidova I.

(Rus)

编号 5 (2014)

SAKhARNYY DIABET: OT PONIMANIYa ETIOLOGII K VYBORU LEChENIYa

Kononenko I., Smirnova O.

(Rus)

编号 5 (2014)

TERAPIYa LIRAGLUTIDOM ZNAChITEL'NO ULUChShAET KONTROL' GLIKEMII I OKAZYVAET POLOZhITEL'NOE VLIYaNIE NA SERDEChNO-SOSUDISTUYu SISTEMU PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA

Kudinov V., Nichitenko M., Chesnikova A.

(Rus)

编号 16 (2013)

Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov

Ushkalova E.

(Rus)

编号 5 (2013)

PREIMUShchESTVA METFORMINA PROLONGIROVANNOGO DEYSTVIYa

Petunina N., Trukhina L., Sinitsyna E., Antsiferov M.

(Rus)

编号 5 (2013)

REGIDRATATsIONNAYa TERAPIYa I VOZMOZhNOSTI EE KONTROLYa U PATsIENTOV S DIABETIChESKIMI KOMAMI (OBZOR LITERATURY)

Legun A., Vetsheva M.

(Rus)

编号 16 (2012)

Mnogofaktornoe upravlenie sakharnym diabetom 2 tipa: kakovy nashi segodnyashnie vozmozhnosti

Galstyan G.

(Rus)

编号 11 (2012)

Osobennosti lecheniya narusheniy tolerantnosti k glyukoze u patsientov s abdominal'no-vistseral'nym tipom ozhireniya na rannikh etapakh ego razvitiya

Shilov A., Abdullaeva A.

(Rus)

编号 3 (2012)

PLACE OF DIBCOR® IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME

Vorokhobina N., Kuznetsova A., Vorohobina N., Kuznetsova A.

编号 3 (2012)

TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®)

Antsiferov M., Petunina N., Antsiferov M., Petunina N.

编号 16 (2011)

DIPEPTIDYL PEPTIDASE-4 INHIBITORS - NEW POTENTIALS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW

Antsiferov M., Antciferov M.

编号 5 (2011)

DIABETIC AUTONOMIC NEUROPATHY AND DIGESTIVE ORGANS

Pogromov A., Baturova V., Pogromov A., Yu Baturova V.

编号 3 (2011)

DIABETIC NEPHROPATHY: DOES ANGIOTENSIN-CONVERTING ENZYME INHIBITORS MAINTAIN PRIORITY POSITION?

Fomin V., Pulin A., Saginova E., Fomun V., Pulin A., Saginova E.

编号 16 (2010)

INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS: A CHOICE AND AN INDIVIDUAL APPROACH

Biryukova Y., Biryukova E.

编号 5 (2010)

Thiazide diuretics and arterial hypertension: the history is going on

E Chazova I., Fomin V., Chazova I., Fomin V.

编号 3 (2010)

Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?

Nedosugova L., Nedosugova L.

编号 17 (2009)

KLINIChESKIE NABLYuDENIYa PATsIENTOV S OSTEOPOROZOM I ENDOKRINNOY PATOLOGIEY

Belyaeva E.

编号 11 (2009)

Peculiarities of antihypertensive therapy in metabolic syndrome and diabetes mellitus

Mychka V., Zhernakova Y., Chazova I., Michka V., Jernakova Y., Chazova I.

编号 3 (2009)

Do all we know about the thiazolidinediones, or what pioglitazone differs from rosiglitazone?

Mkrtumyan A., Mkrtumyan A.

Adherence to modern technologies of glycemic management in diabetic patients

Chernikova N., Prokhorova K., Gancho I.

(Rus)

Diabetes mellitus and periodontal diseases: together or in parallel?

Trukhan D., Sulimov A., Trukhan L.

(Rus)

卷 32, 编号 2 (2025)

Effects of ipragliflozin in patients with type 2 diabetes mellitus, arterial hypertension and left ventricular diastolic dysfunction in a short-term prospective study

Safronova S., Druk I., Kanunnikova O., Korennova O., Podolnaya S., Klepatskaya T., Kalinina I.

(Rus)

Intensification of diabetes therapy using insulin degludec. A series of atypical clinical cases

Smirnova E.

(Rus)

Comparative characteristics of the incidence of various endocrinopathies in cancer patients receiving treatment with immune checkpoint inhibitors

Zhurtova I., Aramisova L., Abdul Moati H., Arkhestova D., Khachmakhova E.

(Rus)

Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation

Ignatenko A., Bagriy A., Prikolota A., Prikolota O., Mikhailichenko E., Golodnikov I., Bagriy O.

(Rus)

The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus

Petrov V., Shatalova O., Klykova M., Stetsky N.

(Rus)

卷 30, 编号 3 (2023)

Glucometer with a mobile application as a system for remote control of diabetes

Koteshkova O., Dukhareva O., Demidov N., Antsiferov M., Golubeva Y.

(Rus)

卷 29, 编号 11/12 (2022)

Clinical effects of dapagliflozin in patients with type 2 diabetes mellitus and paroxysmal atrial fibrillation

Bagriy A., Prikolota O., Prikolota A., Mikhailichenko E., Golodnikov I., Bagriy O., Kotova K.

(Rus)

卷 29, 编号 4 (2022)

Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin

Novikova M., Koteshkova O., Antsiferov M.

(Rus)

卷 28, 编号 12 (2021)

School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus

Lisker A., Volkova A., Chernaya M., Mozgunova V., Durdyeva M.

(Rus)

Experience of using the new ultrafast-acting insulin Fiasp® in patients on insulin pump therapy: a case report

Barsukov I., Demina A.

(Rus)

Predictors of severe course of disease and high mortality among patients with COVID-19 and diabetes mellitus

Ivanova M., Zhurtova I., Sizhazheva S., Gubachikova A.

(Rus)

卷 27, 编号 12 (2020)

Resistin levels and metabolic parameters in patients type 2 diabetes mellitus in combination with hypothyroidism

Verbovoy T., Lomonova T.

(Rus)

卷 27, 编号 4 (2020)

Features of the treatment of patients with type 2 diabetes mellitus and morbid obesity

Amosova M., Gurova O., Fadeev V.

(Rus)

卷 26, 编号 14 (2019)

Statins and the risk of diabetes: an evidence-based review

Leonova M.

(Rus)

卷 26, 编号 4 (2019)

Prevention of blindness in diabetes mellitus. From retinal laser coagulation to pharmacology

Shadrichev F., Demidova T., Grigorieva N., Kozhevnikov A.

(Rus)

卷 26, 编号 3 (2019)

Poststroke recovery in patients with type 2 diabetes mellitus

Tanashyan M., Maksimova M., Antonova K., Raskurazhev A., Shakhparonova N., Romantsova T.

(Rus)

编号 11 (2018)

Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use

Biryukova E.

(Rus)

编号 16 (2017)

Features of urine microflora in diabetic patients

Chikanova A., Khamnuyeva L., Karnoukhova O., Sudakova N., Tokareva N.

(Rus)

编号 9 (2017)

PROBLEMS OF COMORBID PATIENT AND POLYPRAGMASY IN NEUROLOGY

Shishkova V.

(Rus)

编号 5 (2017)

SELF-CONTROL OF GLYCEMIA: SHELFLIFE OF TEST STRIPS IS IMPORTANT

Biryukova E.

(Rus)

编号 16 (2016)

Diabetes mellitus and coronary artery disease: features of clinical manifestation and treatment

Verbovoy A., Sharonova L.

(Rus)

编号 5 (2016)

INCRETIN SYSTEM AS PROMISING PHARMACOLOGICAL TARGET FOR HYPOGLYCEMIC THERAPY

Kurkin D., Volotova E., Bakulin D., Lomkina E., Tyurenkov I.

(Rus)

编号 17 (2015)

Adipokiny i gormonal'no-metabolicheskie pokazateli u bol'nykh sakharnym diabetom 2 tipa i podagroy

Verbovoy A., Tsanava I., Verbovaya N.

(Rus)

编号 9 (2015)

GIPERGLIKEMIYa I OSTRYY KORONARNYY SINDROM

Martynov A., Akatova E., Nikolin O., Urlaeva I.

(Rus)

编号 20 (2014)

Opyt primeneniya Aktovegina v lechenii neyroishemicheskoy formy sindroma «diabeticheskaya stopa»

Dibirov M., Gadzhimuradov R., Khalidov O., Proshin A., Kakubava M.

(Rus)

编号 16 (2014)

Analiz effektivnosti i bezopasnosti primeneniya otechestvennogo insulina Rinsulin NPKh v gorode Nizhniy Novgorod

Zanozina O., Sorokina Y., Lovtsova L., Borovkov N.

(Rus)

编号 5 (2014)

UPRAVLENIE SAKhARNYM DIABETOM: ZNAChENIE STRUKTURIROVANNOGO SAMOKONTROLYa

Antsiferov M., Koteshkova O.

(Rus)

编号 16 (2013)

Osobennosti terapii perenesennogo insul'ta u bol'nykh sakharnym diabetom

Shavlovskaya O.

(Rus)

编号 16 (2013)

Rol' i mesto gipoglikemii v upravlenii sakharnym diabetom 2 tipa

Chernikova N., Antsiferov M.

(Rus)

编号 5 (2013)

PERSPEKTIVNYE STRATEGII V LEChENII DIABETIChESKOY POLINEVROPATII: ROL' ANTIOKSIDANTNOY TERAPII

Gur'eva I., Svetlova O.

(Rus)

编号 5 (2013)

O RATsIONAL'NOM VYBORE FARMAKOTERAPII PRI SAKhARNOM DIABETE 2 TIPA

Biryukova E.

(Rus)

编号 3 (2012)

DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE

Peterkova V., Peterkova V.

编号 16 (2011)

DIABETIC GASTROENTEROPATHY: THE PATHOGENESIS AND DIFFERENTIAL TREATMENT APPROACH (LITERATURE REVIEW)

Demicheva T., Demicheva T.

编号 3 (2011)

INTENSIVE INSULIN THERAPY IN ACUTE CEREBROVASCULAR ACCIDENT

Demidova I., Makova A., Demidova I., Makova A.

编号 3 (2011)

HOW TO ACHIEVE EFFECTIVE GLYCEMIC CONTROL AND REDUCE THE RISK OF VASCULAR COMPLICATIONS DUE TO USING SULFONYLUREA MEDICATIONS

Biryukova E., pl?midmagidsid Y.

编号 16 (2010)

CONTINUOUS SUBCUTANEOUS INSULIN INFUSION: EFFECTIVE METHOD FOR CONTROL OF TYPE 1 DIABETES MELLITUS

Antsiferov M., Koteshkova O., Kleimenova S., Antsiferov M., Koteshkova O., Kleymenova S.

编号 3 (2010)

Common bean (Phaseolus vulgaris L.)/

Samylina I., Sorokina A., Pyatigorskaya N., Samylina I., Sorokina A., Pyatigorskaya N.

编号 3 (2010)

Use of long-acting insulin analogues in type 2 diabetes mellitus treatment (according to the data of international and Russian registries)

Antsiferov M., Antsiferov M.

编号 17 (2009)

LEChENIE BOL'NYKh SAKhARNYM DIABETOM TIPA 2: PROBLEMY I PUTI IKh REShENIYa

Petunina N.

编号 10 (2009)

New directions of drugs Milgamma and Milgamma compositum use in the diabetes mellitus

Den'gin V., Dengin V.

编号 3 (2009)

Diabetic foot syndrome: approaches to treatment of infection

Privol'nev V., Privolnev V.

Blood lipid profile in patients with obesity and type 2 diabetes mellitus and without type 2 diabetes mellitus before and after bariatric surgery

Mozgunova V., Volkova A., Semikova G., Khalimov Y., Vasilevsky D., Balandov S., Anisimova K.

(Rus)